Pulmonary hypertension (PH) is a rare and life threatening lung disorder in which the high blood pressure in the pulmonary arteries could lead to right heart failure. There are many potential causes, such as rheumatic, lung, heart disorders, hypoxia, thromboembolic diseases etc. There are no cures for pulmonary hypertension, and the symptoms vary from person to person. But the earlier it's diagnosed, the better and easier it is to live with the disease.
The 2015 conference, “Annual Update in Pulmonary Hypertension,”
is being organized by Tufts University School of Medicine at Boston Marriott Cambridge on December 4, 2015. This activity designates a maximum of 6.5 AMA PRA Category 1 Credits™. Tufts University School of Medicine (TUSM) is a home to 19 clinical and 4 basic science departments. It is a renowned institution for innovative medical education, health care and advanced research strategies.
The one day program aims to provide an update on the pathophysiology, novel diagnostic and therapeutic approaches for patients affected with Pulmonary Hypertension and is of advantage for physicians (Pulmonology, Cardiology and Rheumatology), fellows, residents, nurse practitioners and healthcare professionals involved in the diagnosis, management and healthcare related to PH. All presentations and sessions will emphasize current evidence-based guidelines, research and patient-centered outcomes. Nicholas S. Hill MD, Jane A. Leopold MD, Ryan J. Tedford MD, Nadine Al Namaani MD are a few of the expert faculty leading the conference sessions.
Conference registration and full scheduled is available at: Link
Cambridge, in all its uniqueness, is a mix of rich communities with cultural and social diversity. The City is a 6.5-mile area harboring top universities, academic institutions, vibrant neighborhoods, art and cultural venues, river sides, museums and restaurants. The variety makes it an exceptional place for intellectual, as well as technological innovation.